SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-189844
Filing Date
2014-05-08
Accepted
2014-05-08 15:41:22
Documents
12
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d714435d10q.htm 10-Q 229062
2 EX-10.1 d714435dex101.htm EX-10.1 36843
3 EX-31.1 d714435dex311.htm EX-31.1 6767
4 EX-31.2 d714435dex312.htm EX-31.2 6877
5 EX-32.1 d714435dex321.htm EX-32.1 5198
12 GRAPHIC g714435g11a90.jpg GRAPHIC 19218
  Complete submission text file 0001193125-14-189844.txt   2203441

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT oxgn-20140331.xml EX-101.INS 224666
7 XBRL TAXONOMY EXTENSION SCHEMA oxgn-20140331.xsd EX-101.SCH 26638
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxgn-20140331_cal.xml EX-101.CAL 27034
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxgn-20140331_def.xml EX-101.DEF 59057
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxgn-20140331_lab.xml EX-101.LAB 215257
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxgn-20140331_pre.xml EX-101.PRE 133916
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 14824680
SIC: 2836 Biological Products, (No Diagnostic Substances)